Lymphocyte-activation gene 3 in cancer immunotherapy: function, prognostic biomarker and therapeutic potentials

Ke Ren, Hayam Hamdy, Abdo Meyiah, Eyad Elkord*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Fingerprint

Dive into the research topics of 'Lymphocyte-activation gene 3 in cancer immunotherapy: function, prognostic biomarker and therapeutic potentials'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology